Efficacy and safety of transoral incisionless fundoplication in non-obese and obese adults: a population-based cohort study from the United States - Scorecard - MDSpire

Efficacy and safety of transoral incisionless fundoplication in non-obese and obese adults: a population-based cohort study from the United States

  • By

  • Fouad Jaber

  • Saltenat Moghaddam Adames

  • Mohamed Jaber

  • Kinan Obiedat

  • Kalpesh Patel

  • Teminioluwa A. Ajayi

  • Roy Tomas DaVee

  • Fares W. Ayoub

  • Nirav Thosani

  • Wasseem Skef

  • July 2, 2026

  • 0 min

Share

Clinical Scorecard: Effectiveness and safety of transoral incisionless fundoplication in adults with varying body weights: findings from a U.S. population-based cohort study

At a Glance

CategoryDetail
ConditionGastroesophageal reflux disease (GERD)
Key MechanismsTransoral incisionless fundoplication (TIF) repairs the anti-reflux barrier via flap valve reconstruction, restoring the angle of His, and augmenting the high-pressure zone at the lower esophageal sphincter.
Target PopulationAdults aged ≥ 18 years with chronic symptomatic GERD
Care SettingU.S. population-based cohort study using electronic medical records

Key Highlights

  • TIF is effective for patients with axial hernia < 2 cm or hiatus diameters < 3 cm.
  • TIF has comparable efficacy to surgical fundoplication in appropriately selected patients.
  • BMI ≥ 35 kg/m2 is a relative contraindication for TIF.
  • Class 1 obesity (BMI 30–34.9 kg/m2) represents a significant cohort of GERD patients.
  • Combining TIF with cruroplasty shows comparable short-term efficacy and excellent safety.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of GERD should be confirmed using validated ICD-10 codes.

Management

  • Consider TIF for patients with axial hernia < 2 cm or hiatus diameters < 3 cm.

Monitoring & Follow-up

  • Monitor for postoperative new PPI recidivism and incidence of post-TIF esophagitis.

Risks

  • Higher fundoplication failure rates with increasing BMI and potential for perioperative complications.

Patient & Prescribing Data

Adults with GERD stratified by BMI: non-obese (BMI < 30 kg/m2) and class I obesity (BMI 30–34.9 kg/m2).

TIF may be effective in class I obesity, but BMI ≥ 35 kg/m2 is a contraindication.

Clinical Best Practices

  • Perform one-to-one propensity score matching to minimize confounding.
  • Assess covariate balance post-matching to ensure comparability between BMI cohorts.

Related Resources & Content

Original Source(s)

Related Content